Quest Exercises Option on Clinical Genomics Colon Cancer Markers | GenomeWeb

NEW YORK (GenomeWeb News) – Australian firm Clinical Genomics today said that Quest Diagnostics has exercised an option to use the firm's gene-based biomarkers in the development of new tests for colon cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.